2021 Archive

Through decades of research Elaine Tuomanen, MD, made crucial contributions to the creation of the first universal vaccine for pneumonia – now in clinical trials.

See how the CAP Fellowship is emerging as a competitive full-time career training experience for St. Jude postdocs.

See how St. Jude is working to counteract the rise of antifungal resistance

Translational research from Suzanne Baker, PhD, and colleagues shows that targeted MET inhibitor capmatinib effectively crosses the blood-brain-barrier, synergizing with radiation to treat pediatric high-grade glioma.

Explore how St. Jude researchers are tackling the silent pandemic of antibiotic resistance and pioneering the development of new drugs to address the growing threat.

See how the St. Jude BioHackathon solves research problems and builds community. 

Explore how St. Jude has and continues to lead infectious diseases research to prevent infections in children with compromised immune systems. 

Childhood cancer survivors are at an increased risk of major adverse cardiovascular events, making safeguarding heart health a priority.

Find out how Victor Torres, PhD, Department of Host-Microbe Interactions chair, is leading research on antimicrobial resistant pathogens.

Learn how Richard Finkel, MD, is developing the Center for Experimental Neurotherapeutics to be the gold standard in pediatric neurological disease treatment development

Kristin Lyons, director of Rehabilitation Services, and Jessica Sparrow, Lead Occupational Therapist, worked as part of a team of oncology rehabilitation providers from pediatric institutions across the country to co-author a recent Seminars in Oncology Nursing article, which provides a comprehensive overview of rehabilitation screening, assessment, and intervention for children with cancer.

Posterior fossa syndrome develops in some children following surgery for the brain tumor medulloblastoma. St. Jude research offers fresh insight into the mysterious syndrome and advice on how to avoid it.

The National Comprehensive Cancer Network recently published treatment guidelines for children diagnosed with nephroblastoma. Two St. Jude physicians collaborated on the project.

As cancer survivorship changes, new benchmarks must be set to redefine survivorship research and treatment success.

It’s essential to provide an accurate, science-based website for vaccine information. The St. Jude Global COVID-19 Working Group plans to provide accurate COVID-19 information, including answering questions and providing vaccine news as it emerges.

St. Jude Children’s Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases.

Cancer treatments can result in damage to the heart both during treatment and years following completion of therapy. As many cancer survivors are now living longer into adulthood, we’re gaining a better understanding of some of the late effects of cancer treatments that we weren’t able to observe before.

Scientists are learning more about antibody production in response to flu, including how they develop from helper T cells and monocytes.

The pandemic exposed shortcomings in health care. But this study revealed more than expected in this type of children’s treatment.

Tangie Thomas, MPH, is vice president of Clinical Trials Operations at St. Jude Children’s Research Hospital.